Elsevier Announces the Winner of the 4th Ahmed Zewail Prize in Molecular Sciences
Professor Noel S. Hush from the University of Sydney, Australia rewarded for his outstanding contributions to electron transfer processes
Amsterdam, 26 September, 2012– Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the editors of the leading international journal Chemical Physics Letters are pleased to announce that the 4th Ahmed Zewail Prize in Molecular Sciences has been awarded to Professor Noel S. Hush from The University of Sydney, Australia for his outstanding contributions to electron transfer processes.
Professor Hush developed theories with broad applications for predicting and explaining electron transfer processes. His elegant theories take into account both solvent reorganization and the inner structure of a molecular complex. He also explained how electrons transfer between species covalently linked by bridging molecules. His work has had wide impact in fields ranging from corrosion to solar energy to photosynthesis.
Nobel Laureate Professor Ahmed Zewail, in whose name the Prize is honoured, remarked, "Noel has made profound contributions to molecular science. Over six decades, he continues his creative work on various frontiers, from electron transfer theory to molecular electronics. I am delighted that he has been awarded the prize.”
Rob van Daalen, Publisher Chemical Physics Letters at Elsevier added, “I am delighted with the choice of Professor Hush as the 4th Ahmed Zewail Prize winner. I thank both the nominators and the leading scientists in the Voting Committee, who helped the Editors in making such an exceptional choice from a field of very strong nominations.”
The prize consists of a monetary award of $20,000 and will be presented during the 2013 Spring meeting of the American Chemical Society, in New Orleans, USA (7-11 April 2013).
# # #
About Professor Noel S. Hush
Noel Sydney Hush is Emeritus Professor of the School of Molecular and Microbial Biosciences at the University of Sydney. He has been at the University for over thirty years and was its founder of the Theoretical Chemistry discipline. Before arriving at the University of Sydney, Hush worked in England at the universities of Manchester and Bristol. He has also held numerous prestigious visiting scientist posts at universities in Australia, the United Kingdom and the United States of America. Noel Hush is author of well over two hundred publications and is a Fellow of the Australian Academy of Science, Royal Australian Chemical Institute and the Royal Society (UK). He was appointed a Commander Officer of the Order of Australia (AO) for his services in 1993.
More information: http://www.eoas.info/biogs/P004656b.htm
About the Ahmed Zewail Prize in Molecular Sciences
The Ahmed Zewail Prize in Molecular Sciences is a biennial award sponsored by Elsevier in collaboration with the international journalChemical Physics Letters. Named for the journal’s Honorary Advisory Editor Professor Zewail, who received the 1999 Nobel Prize in Chemistry, the Prize is awarded to individual scientists who have made significant and creative contributions of a fundamental nature to any of the disciplines of molecular sciences. The winner’s research activities may cover theoretical and/or experimental aspects of the studies in all phases of matter and biological systems. The Prize consists of a monetary award of $20,000, a Gold Medal and a certificate, and will be presented in person at a special symposium during the Annual Spring meetings of the American Chemical Society. For more information: www.elsevier.com/ahmedzewailprize
About Chemical Physics Letters
Chemical Physics Letters is an international rapid communications journal publishing the results of frontier research in chemical physics and physical chemistry, molecular sciences, materials science and biological systems. The Editors of the Journal are currently Professors David Clary (University of Oxford, UK), Mitchio Okumura (California Institute of Technology, USA), Richard Saykally (University of California, Berkeley, USA) and Villy Sundström (Lund University, Sweden). The Editors are supported by an Advisory Editorial Board of about 100 leading scientists. For more information: www.elsevier.com/locate/cplett
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
+31 20 4853506